EP3237398
QUINAZOLINE DERIVATIVES USED TO TREAT HIV
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.12.2015EP published:
19.12.2018EP application number:
15832711.4
EPO information:
European Patent Register
Max expiry date:
22.12.2035
Title:
QUINAZOLINE DERIVATIVES USED TO TREAT HIV
Timeline
Today
23.12.2015EP application
19.12.2018EP Publication
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, 94404, Foster City, CA, US
Name:
Institute of Organic Chemistry and Biochemistry AS CR, V.V.I.Address:
Flemingovo nam. 2, 16610 Praha 6, CZ
Inventor
Name:
JANSA, PetrAddress:
Foster City, CA, US
Name:
SIMON, PetrAddress:
166 10 Praha 6, CZ
Name:
LANSDON, EricAddress:
Foster City, CA, US
Name:
HU, Yunfeng, EricAddress:
CA, US
Name:
BASZCZYNSKI, OndrejAddress:
166 10 Praha 6, CZ
Name:
DEJMEK, MilanAddress:
166 10 Praha 6, CZ
Name:
MACKMAN, Richard, L.Address:
Foster City, CA, US
Priority
Number:
201462096748 PDate:
24.12.2014Country:
US
Classification
Categories:
C07D 401/12, C07D 239/94, A61K 31/517, A61P 31/18